Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

This study has been completed.
Information provided by:
Merck Sharp & Dohme Corp. Identifier:
First received: September 21, 2004
Last updated: May 21, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2004 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):